Ursula Ehmer

8PUBLICATIONS
86CO-AUTHORS
Haematological tumoursCancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 19, 2026
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI Registry.

|Apr 18, 2026
Development and Release of the Munich UICC Staging Tool (MUST): Advancing UICC Staging in Real-World Data With Insights From Pancreatic and Stomach Cancer.

|May 12, 2025
Activation of RAS/MEK/ERK signalling drives biliary differentiation in primary liver cancer.

Thomas Rösner, Carina Rupp, Christian Lechler

|Mar 28, 2025
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study.

Christian Möhring, Moritz Berger, Farsaneh Sadeghlar

|Nov 04, 2024
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.

Tiago de Castro, Sabrina Welland, Leonie Jochheim

|Jul 29, 2023
Fulminant Liver Failure after Treatment with a Checkpoint Inhibitor for Gastric Cancer: A Case Report and Review of the Literature.

Miriam Dibos, Johanna Dumoulin, Carolin Mogler

Pageof 2

Frequent Collaborators

3 joint publications

Najib Ben Khaled

3 joint publications

Marino Venerito

3 joint publications

Arndt Weinmann

2 joint publications

Arndt Vogel